clinical trial · NCT07670702
An Evaluation of the Long-Term Safety and Efficacy of TSND-201 for the Treatment of PTSD
Post Traumatic Stress DisorderTSND-201
brief summary
This study is evaluating the long-term safety and efficacy of TSND-201 in adults with PTSD. Participants that have completed a double-blind clinical trial with TNSD-201 for PTSD will be invited to participate in this open-label extension trial. Each participant will be able to receive up to three Treatment Courses over the duration of the study (up to 48 weeks). Each Treatment Course includes 4 dosing sessions, spaced one week apart.
started
Jun 22, 2026
primary completion
Dec 1, 2028
completion
Jan 1, 2029
last updated
Sep 4, 2026
official title
A Phase 3 Open-Label Extension Study to Assess the Long-term Safety and Efficacy of TSND-201 for the Treatment of PTSD
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol